Annette S. Kim, M.D., Ph.D., is the Henry Clay Bryant Professor and Division Director of Diagnostic Genetics and Genomics at the University of Michigan.
She received her MD, PhD from Harvard. After a postdoc at Memorial Sloan Kettering Institute and several years at Merck, Dr. Kim completed residency and fellowship in Hematopathology at the University of Pennsylvania.
Dr. Kim has been the Medical Director at Cooper University Hospital and hematopathologist and molecular pathologist at Vanderbilt University (7 years) and Brigham and Women’s Hospital (8.5 years).
Dr. Kim has been awarded the Damon Runyon–Walter Winchell Fellowship and the Doris Duke Clinician Scientist Development Award.
Her research program has focused on the study of hematolymphoid malignancies, including miRNAs in myelodysplastic syndromes, myeloid and lymphoid mutational patterns, and test utilization management.
She has served as a member of Molecular Oncology Committee and is currently Vice-Chair of the Personized Healthcare Committee for College of American Pathologists. She is also the Chair of the ASH Precision Medicine committee.
Dr. Kim has served on the Association of Molecular Pathology Board and Executive Committees as well as chairing the Hematopathology Subdivision and the Training and Education Committees and is the Program Chair-elect. She has been awarded several teaching awards and was awarded the CAP Public Service Award in 2019.
.jpg)
Annette Kim, M.D., Ph.D.